The impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant

Tacrolimus is a first-line immunosuppressant used after solid organ transplantation that suffers from extensive intra- and inter-patient variability and a narrow therapeutic window. Tacrolimus clearance is predominantly mediated by CYP3A4 and CYP3A5 , with evidence indicating that pharmacogenetic (PG) differences in these enzymes drive significant changes in tacrolimus pharmacokinetics (PK) and therapeutic tacrolimus dosing. The current study investigates the hypothesis that CYP3A4/5 genetic variation alters tacrolimus dose requirement and metabolite concentration in children following pediatric heart transplant. Saliva and whole blood samples were collected from children who previously received a heart transplant as part of a tacrolimus PG/PK study. A total of 64 children were included in the analysis, which found that children carrying a CYP3A5*1 allele required a 2.7-fold higher tacrolimus dose (p < 0.0001) than individuals with the CYP3A5*3/*3 genotype. Weight-adjusted dose-normalized concentrations of tacrolimus (p < 0.0001) and its M-I (p = 0.0049) and M-II (p = 0.0043) metabolites were significantly lower in children with the CYP3A5*1 allele. Combined, these data support the impact of CYP3A5 genotype on tacrolimus PK and demonstrate the need for larger studies to confirm the clinical importance of this genotype for appropriate tacrolimus dosing in pediatric heart transplant recipients.

Authors

Institutions

Publication Details

Journal
The Pharmacogenomics Journal
Published
2026-11-15
DOI
https://doi.org/10.1038/s41397-026-00435-z
Citations
1
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
2.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant

Kimberly M. Molina, Cassandra E. Deering‐Rice, Joseph E. Rower, Tia S Freeman
1 citations
The Pharmacogenomics Journal
Pharmacogenetics and Drug Metabolism
2.93
article

The impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant

Kimberly M. Molina, Cassandra E. Deering‐Rice, Joseph E. Rower, Tia S Freeman
article en
1 citations

Abstract

Tacrolimus is a first-line immunosuppressant used after solid organ transplantation that suffers from extensive intra- and inter-patient variability and a narrow therapeutic window. Tacrolimus clearance is predominantly mediated by CYP3A4 and CYP3A5 , with evidence indicating that pharmacogenetic (PG) differences in these enzymes drive significant changes in tacrolimus pharmacokinetics (PK) and therapeutic tacrolimus dosing. The current study investigates the hypothesis that CYP3A4/5 genetic variation alters tacrolimus dose requirement and metabolite concentration in children following pediatric heart transplant. Saliva and whole blood samples were collected from children who previously received a heart transplant as part of a tacrolimus PG/PK study. A total of 64 children were included in the analysis, which found that children carrying a CYP3A5*1 allele required a 2.7-fold higher tacrolimus dose (p < 0.0001) than individuals with the CYP3A5*3/*3 genotype. Weight-adjusted dose-normalized concentrations of tacrolimus (p < 0.0001) and its M-I (p = 0.0049) and M-II (p = 0.0043) metabolites were significantly lower in children with the CYP3A5*1 allele. Combined, these data support the impact of CYP3A5 genotype on tacrolimus PK and demonstrate the need for larger studies to confirm the clinical importance of this genotype for appropriate tacrolimus dosing in pediatric heart transplant recipients.

The Pharmacogenomics JournalVol. 26(6)
Intermountain Healthcare (US), Primary Children's Hospital (US), University of Utah (US)
National Institutes of Health, National Heart, Lung, and Blood Institute
Good health and well-being
Openalex Percentile: Top 18%
Pharmacogenetics and Drug Metabolism
2.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon